These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 36458585)
21. Toxicity and biodistribution assessment of curcumin-coated iron oxide nanoparticles: Multidose administration. Aboushoushah S; Alshammari W; Darwesh R; Elbaily N Life Sci; 2021 Jul; 277():119625. PubMed ID: 34015288 [TBL] [Abstract][Full Text] [Related]
22. Multifunctional Iron Oxide Magnetic Nanoparticles for Biomedical Applications: A Review. Tran HV; Ngo NM; Medhi R; Srinoi P; Liu T; Rittikulsittichai S; Lee TR Materials (Basel); 2022 Jan; 15(2):. PubMed ID: 35057223 [TBL] [Abstract][Full Text] [Related]
23. Programmable Assembly of Iron Oxide Nanoparticles Using DNA Origami. Meyer TA; Zhang C; Bao G; Ke Y Nano Lett; 2020 Apr; 20(4):2799-2805. PubMed ID: 32208663 [TBL] [Abstract][Full Text] [Related]
24. Gold-coated magnetic nanoparticle as a nanotheranostic agent for magnetic resonance imaging and photothermal therapy of cancer. Eyvazzadeh N; Shakeri-Zadeh A; Fekrazad R; Amini E; Ghaznavi H; Kamran Kamrava S Lasers Med Sci; 2017 Sep; 32(7):1469-1477. PubMed ID: 28674789 [TBL] [Abstract][Full Text] [Related]
25. Shape-, size- and structure-controlled synthesis and biocompatibility of iron oxide nanoparticles for magnetic theranostics. Xie W; Guo Z; Gao F; Gao Q; Wang D; Liaw BS; Cai Q; Sun X; Wang X; Zhao L Theranostics; 2018; 8(12):3284-3307. PubMed ID: 29930730 [TBL] [Abstract][Full Text] [Related]
26. In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody. Ding N; Sano K; Kanazaki K; Ohashi M; Deguchi J; Kanada Y; Ono M; Saji H Mol Imaging Biol; 2016 Dec; 18(6):870-876. PubMed ID: 27351762 [TBL] [Abstract][Full Text] [Related]
27. Toward absolute quantification of iron oxide nanoparticles as well as cell internalized fraction using multiparametric MRI. Girard OM; Ramirez R; McCarty S; Mattrey RF Contrast Media Mol Imaging; 2012; 7(4):411-7. PubMed ID: 22649047 [TBL] [Abstract][Full Text] [Related]
28. In vivo assessment of the toxic impact of exposure to magnetic iron oxide nanoparticles (IONPs) using Drosophila melanogaster. Güneş M; Aktaş K; Yalçın B; Burgazlı AY; Asilturk M; Ünşar AE; Kaya B Environ Toxicol Pharmacol; 2024 Apr; 107():104412. PubMed ID: 38492762 [TBL] [Abstract][Full Text] [Related]
29. Iron Oxide Nanoparticles in Mesenchymal Stem Cell Detection and Therapy. Mehta KJ Stem Cell Rev Rep; 2022 Oct; 18(7):2234-2261. PubMed ID: 35103937 [TBL] [Abstract][Full Text] [Related]
30. Effects of iron oxide nanoparticles as T Yang H; Wang H; Wen C; Bai S; Wei P; Xu B; Xu Y; Liang C; Zhang Y; Zhang G; Wen H; Zhang L J Nanobiotechnology; 2022 Mar; 20(1):98. PubMed ID: 35236363 [TBL] [Abstract][Full Text] [Related]
31. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer. Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412 [TBL] [Abstract][Full Text] [Related]
32. Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy. Feng Q; Zhang Y; Zhang W; Hao Y; Wang Y; Zhang H; Hou L; Zhang Z Acta Biomater; 2017 Feb; 49():402-413. PubMed ID: 27890732 [TBL] [Abstract][Full Text] [Related]
33. Iron oxide nanoparticle platform for biomedical applications. Xie J; Huang J; Li X; Sun S; Chen X Curr Med Chem; 2009; 16(10):1278-94. PubMed ID: 19355885 [TBL] [Abstract][Full Text] [Related]
34. Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain. Israel LL; Galstyan A; Holler E; Ljubimova JY J Control Release; 2020 Apr; 320():45-62. PubMed ID: 31923537 [TBL] [Abstract][Full Text] [Related]
35. Ultrashort echo time (UTE) imaging of receptor targeted magnetic iron oxide nanoparticles in mouse tumor models. Wang L; Zhong X; Qian W; Huang J; Cao Z; Yu Q; Lipowska M; Lin R; Wang A; Yang L; Mao H J Magn Reson Imaging; 2014 Nov; 40(5):1071-81. PubMed ID: 25485347 [TBL] [Abstract][Full Text] [Related]
36. Hepatotoxic and Neurotoxic Potential of Iron Oxide Nanoparticles in Wistar Rats: a Biochemical and Ultrastructural Study. Mabrouk M; Ibrahim Fouad G; El-Sayed SAM; Rizk MZ; Beherei HH Biol Trace Elem Res; 2022 Aug; 200(8):3638-3665. PubMed ID: 34704196 [TBL] [Abstract][Full Text] [Related]
37. T₁-weighted ultrashort echo time method for positive contrast imaging of magnetic nanoparticles and cancer cells bound with the targeted nanoparticles. Zhang L; Zhong X; Wang L; Chen H; Wang YA; Yeh J; Yang L; Mao H J Magn Reson Imaging; 2011 Jan; 33(1):194-202. PubMed ID: 21182139 [TBL] [Abstract][Full Text] [Related]
38. New Insights into Biocompatible Iron Oxide Nanoparticles: A Potential Booster of Gene Delivery to Stem Cells. Zhang T; Xu Q; Huang T; Ling D; Gao J Small; 2020 Sep; 16(37):e2001588. PubMed ID: 32725792 [TBL] [Abstract][Full Text] [Related]
39. Iron Oxide Nanoparticles as T Jeon M; Halbert MV; Stephen ZR; Zhang M Adv Mater; 2021 Jun; 33(23):e1906539. PubMed ID: 32495404 [TBL] [Abstract][Full Text] [Related]
40. Biodistribution and targeting properties of iron oxide nanoparticles for treatments of cancer and iron anemia disease. Alphandéry E Nanotoxicology; 2019 Jun; 13(5):573-596. PubMed ID: 30938215 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]